News | September 22, 2009

Philips, Maquet Integrate Surgical Table, Cardiovascular X-Ray System

September 22, 2009 - At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Royal Philips Electronics today announced that it will integrate the MAQUET ‘Magnus’ surgical table with Philips’ cardiovascular X-ray systems to create an efficient ‘hybrid operating room’ environment for a full range of minimally-invasive and open surgical procedures.

Worldwide, there has been a shift away from open surgical procedures as hospitals increasingly move towards more same-day and minimally invasive surgery. As a result, over half of patients leave hospital on the same day as their operation. Catheter-based cardiac treatments have also seen a large rise in comparison with open vascular procedures. As a result, hospitals today require rooms for minimally invasive procedures that are flexible and easily adaptable, and are able to accommodate the full range of current and future surgical technologies.

The solution provided by Philips and MAQUET will offer a cost-effective response to this changing healthcare landscape by optimizing workflow and simplifying the room planning and installation process. The tailored, simplified work environment will help increase the efficiency of procedures and decrease the amount of time that the patient spends in hospital.

“As a global leader in providing X-ray solutions for minimally invasive cardiovascular procedures, we work closely with our customers to listen to and act on their feedback. One message that came back strongly was the need for hybrid operating rooms that offer greater flexibility,” said Bert van Meurs, senior vice president of Cardiovascular X-ray at Philips Healthcare. “By integrating MAQUET’s Magnus table we can allow both minimally invasive procedures and open surgery to take place in a single space, simplifying the clinicians’ work environment.”

At TCT Philips also unveiled the ‘3D Heart Navigator’ interventional tool, which combines 3D CT images of a patients’ cardiac anatomy captured before a procedure into a single image with an overlay of the live X-ray fluoroscopy information. Clinicians attending TCT will be able to view a percutaneous aortic valve device implantation procedure using the 3D Heart Navigator solution that will be broadcast live from Catharina Hospital, Eindhoven, the Netherlands.

“The combined emergence of transcatheter valves and sophisticated interventional tools like Philips’ 3D Heart Navigator means that we’re able to have a major positive impact on the lives of a group of patients who we would’ve previously been unable to help,” commented Dr. J.J. Koolen, head of the department of cardiology, Catharina Hospital. “Replacing a valve in a beating heart is a very challenging procedure. By combining static 3D images with the live 2D image we get a much better understanding of the patient’s anatomy, helping us to achieve the best clinical outcome.”

The solution combining Philips’ Allura interventional X-ray solutions and MAQUET’s Magnus OR table, as well as the Philips 3D Heart Navigator Tool, are scheduled for commercial release in 2010. The live procedure from Catharina Hospital will be presented at 9:30 a.m. PDT, Thursday, Sept. 24.

For more information: www.medical.philips.com

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init